Filter results

Clinical Studies


Contact Us for the Latest Status

  • Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (COLCORONA) Scottsdale/Phoenix, Ariz. This is a phase 3, multi-center, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of colchicine in adult patients diagnosed with COVID-19 infection and have at least one high-risk criterion. Approximately 6000 subjects meeting all inclusion and no exclusion criteria will be randomized to receive either colchicine or placebo tablets for 30 days.

Closed for Enrollment